Future work can address if induction of linc-ADAIN (e.g., through RNA activation) in obese adipose in vivo can provide anti-inflammatory and adipose remodeling effects that may attenuate the cardiometabolic complications of obesity. Here, LINC-ADAIN is linked to obesity due to melanocortin 4 receptor deficiency.